panCELLa granted patent in the United Kingdom for induced Allogeneic Cell Tolerance (iACT Stealth) Technology Pluristyx and panCELLa today are excited to announce the granting of a patent used in
Investegate announcements from Kadimastem, Kadimastem and Implant Therapeutics, Inc. Sign an Evaluation Agreement Towards the Potential Licensing of “Immune Evasive” Cells
DGAP-News: Kadimastem Kadimastem and Implant Therapeutics, Inc. Sign an Evaluation Agreement Towards the Potential Licensing of "Immune Evasive" Cells 08.06.2022 / 13:00 The issuer